SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-003824
Filing Date
2021-02-09
Accepted
2021-02-09 07:35:11
Documents
3
Period of Report
2021-02-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10019904_8k.htm 8-K 22042
2 EXHIBIT 99.1 brhc10019904_ex99-1.htm EX-99.1 21147
3 image00002.jpg GRAPHIC 1869
  Complete submission text file 0001140361-21-003824.txt   47209
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 21603947
SIC: 2834 Pharmaceutical Preparations